Equity Overview
Price & Market Data
Price: $8.39
Daily Change: +$0.406 / 4.84%
Daily Range: $8.33 - $8.73
Market Cap: $1,300,228,864
Daily Volume: 120,007
Performance Metrics
1 Week: -1.36%
1 Month: -20.04%
3 Months: 10.07%
6 Months: -15.64%
1 Year: 22.02%
YTD: 18.75%
Company Details
Employees: 749
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Serum Life Sciences Limited for the to develop, manufacture, and commercialize the COVID-19 vaccine. The company was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.